Mobile

Liraglutide Effect and Action in Diabetes (LEAD-5): Effects on glycaemic control after once daily administration of liraglutide in combination with glimepiride and metformin versus glimepiride and met...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-003415-71

Liraglutide Effect and Action in Diabetes (LEAD-5): Effects on glycaemic control after once daily administration of liraglutide in combination with glimepiride and metformin versus glimepiride and metformin combination therapy, and versus insulin glargine added to glimepiride and metformin combination therapy in subjects with type 2 diabetes. A six-month randomised, double-blind, parallel-group, multi-centre, multi-national trial with an open-label treat-to-target insulin glargine control arm

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess and compare the effect on glycaemic control (as measured by HbA1c) of once daily administration of liraglutide in combination with glimepiride and metformin versus glimepiride and metformin combination therapy, and versus insulin glargine added to glimepiride and metformin combination therapy in subjects with type 2 diabetes.

Critère d'inclusion

  • Diabetes Mellitus

Liens